| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10732883 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 675 journal articles in the PubMed database | Email to a friend | | |
| Kjøller-Hansen L, Steffensen R, Grande P
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Am Coll Cardiol 2000 Mar 15; 35(4):881-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kjøller-Hansen L, Steffensen R, Grande P
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Am Coll Cardiol 2001 Apr; 37(5):1214-20.
Abstract | Full Citation | Find Related Articles | | Kjøller-Hansen L, Steffensen R, Grande P
Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES). [Clinical Trial, Journal Article, Randomized Controlled Trial]
Am Heart J 2004 Sep; 148(3):475-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kjøller-Hansen L, Steffensen R, Grande P
The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Scand Cardiovasc J 1998; 32(4):225-32.
Abstract | Full Citation | Find Related Articles | | Yusuf S, Sleight P, Pogue J, et al.
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2000 Jan 20; 342(3):145-53.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Teo KK, Mitchell LB, Pogue J, et al.
Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Circulation 2004 Sep 14; 110(11):1413-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kjøller-Hansen L, Steffensen R, Grande P
Effect of ramipril on postrevascularization prevalence of angina and quality of life. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Int J Cardiol 2004 Jun; 95(2-3):159-65.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rouleau JL, Warnica WJ, Baillot R, et al.
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. [Journal Article, Research Support, Non-U.S. Gov't]
Circulation 2008 Jan 1; 117(1):24-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Køber L, Torp-Pedersen C, Carlsen JE, et al.
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 1995 Dec 21; 333(25):1670-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
